MedPath
NMPA Approval

Tizanidine Hydrochloride Tablets

国药准字H20050788

December 18, 2019

Drug Information

盐酸替扎尼定片

凯莱通

凯莱通

片剂

4mg(按C9H8ClN5S计)

化学药品

December 18, 2019

Company Information

Applicant Company

四川省泸州国家高新区医药产业园

Manufacturing Company

四川省泸州国家高新区医药产业园曲河西路8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸替扎尼定片 - NMPA 批准文号 | MedPath